These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 97051)

  • 21. Gold nephropathy in rats--light and electron microscopic studies.
    Nagi AH; Alexander F; Barabas AZ
    Exp Mol Pathol; 1971 Dec; 15(3):354-62. PubMed ID: 4944446
    [No Abstract]   [Full Text] [Related]  

  • 22. Proteinuria in rheumatoid arthritis--drug-induced or amyloid?
    Bourke BE; Woodrow DF; Scott JT
    Ann Rheum Dis; 1981 Jun; 40(3):240-4. PubMed ID: 6787994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
    Otto W; Pietruschka WD; Beenken O
    Z Gesamte Inn Med; 1975 Aug; 30(15):507-9. PubMed ID: 1189496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 26. Gold nephropathy prototype of membranous glomerulonephritis.
    Tönroth T; Skrifvars B
    Am J Pathol; 1974 Jun; 75(3):573-90. PubMed ID: 4600774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
    Trnavský K; Zbojanová M
    Fysiatr Revmatol Vestn; 1979 Apr; 57(2):87-91. PubMed ID: 570949
    [No Abstract]   [Full Text] [Related]  

  • 28. Concurrent naproxen- and penicillamine-induced renal disease in rheumatoid arthritis.
    Quigley MR; Richfield M; Krumlovsky FA; Kanwar YS; Carone FA; Jarrett MP
    Arthritis Rheum; 1982 Aug; 25(8):1016-9. PubMed ID: 7115444
    [No Abstract]   [Full Text] [Related]  

  • 29. Iron overload nephropathy in rats.
    Richter GW
    Pathol Res Pract; 1980; 168(1-3):84-106. PubMed ID: 6159614
    [No Abstract]   [Full Text] [Related]  

  • 30. Difficulties in the use of D-penicillamine in the treatment of rheumatoid arthritis.
    Stockman A; Richter D; Barraclough D; Muirden KD; Macdonald I; Kincaid-Smith P
    Aust N Z J Med; 1979 Oct; 9(5):495-503. PubMed ID: 294903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunofluorescent and morphological studies in congenital nephrotic syndrome.
    Rapola J; Savilahti E
    Acta Paediatr Scand; 1971 May; 60(3):253-63. PubMed ID: 4931555
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal morphological and immunological changes associated with acute viral hepatitis.
    Eknoyan G; Györkey F; Dichoso C; Martinez-Maldonado M; Suki WN; Györkey P
    Kidney Int; 1972 Jun; 1(6):413-9. PubMed ID: 4365635
    [No Abstract]   [Full Text] [Related]  

  • 33. Nephropathy of congenital syphilis.
    Rosen EU; Abrahams C; Rabinowitz L
    S Afr Med J; 1973 Sep; 47(35):1606-9. PubMed ID: 4270175
    [No Abstract]   [Full Text] [Related]  

  • 34. Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure.
    Elsas LJ; Hayslett JP; Spargo BH; Durant JL; Rosenberg LE
    Ann Intern Med; 1971 Sep; 75(3):427-33. PubMed ID: 5315082
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of nephritogenicity of systemic activation of the alternate complement pathway.
    Verroust PJ; Wilson CB; Dixon FJ
    Kidney Int; 1974 Sep; 6(3):157-69. PubMed ID: 4607423
    [No Abstract]   [Full Text] [Related]  

  • 36. IgM nephropathy associated with penicillamine.
    Rehan A; Johnson K
    Am J Nephrol; 1986; 6(1):71-4. PubMed ID: 3963062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrano-proliferative glomerulonephritis associated with persistent viral hepatitis.
    Myers BD; Griffel B; Naveh D; Jankielowiiz T; Klajman A
    Am J Clin Pathol; 1973 Aug; 60(2):222-8. PubMed ID: 4198287
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-induced proteinuria.
    Matthes KJ
    Contrib Nephrol; 1981; 24():109-14. PubMed ID: 7226810
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of penicillamine on the kidney.
    Davison AM; Day AT; Golding JR; Thomson D
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):109-13. PubMed ID: 122655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resumption of treatment with penicillamine after proteinuria.
    Hill H; Hill A; Davison AM
    Ann Rheum Dis; 1979 Jun; 38(3):229-31. PubMed ID: 485579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.